Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Interpace Diag Grp (IDXG)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 27,764
  • Shares Outstanding, K 38,096
  • Annual Sales, $ 21,900 K
  • Annual Income, $ -12,190 K
  • 60-Month Beta 2.57
  • Price/Sales 1.30
  • Price/Cash Flow N/A
  • Price/Book 0.65
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.44
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date 05/21/19
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 4 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/19
See More
  • Average Estimate -0.08
  • Number of Estimates 1
  • High Estimate -0.08
  • Low Estimate -0.08
  • Prior Year -0.11
  • Growth Rate Est. (year over year) +27.27%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.67 +8.46%
on 04/22/19
0.85 -14.14%
on 04/05/19
-0.11 (-13.11%)
since 03/25/19
3-Month
0.67 +8.46%
on 04/22/19
1.04 -29.83%
on 03/04/19
-0.12 (-14.14%)
since 01/25/19
52-Week
0.67 +8.46%
on 04/22/19
1.78 -59.00%
on 09/20/18
-0.18 (-19.36%)
since 04/25/18

Most Recent Stories

More News
Interpace Diagnostics Announces New York State Approval

State of New York Approves Commercialization of ThyraMIR(R) Now in Three Specimens

IDXG : 0.70 (-4.11%)
New Research: Key Drivers of Growth for Capital One Financial, ServiceSource International, Pfenex, eMagin, Interpace Diagnostics Group, and Rubicon Technology -- Factors of Influence, Major Initiatives and Sustained Production

In new independent research reports released early this morning, Capital Review released its latest key findings for all current investors, traders, and shareholders of Capital One Financial Corporation...

PFNX : 5.78 (-1.87%)
EMAN : 0.59 (+1.72%)
SREV : 1.01 (-0.99%)
IDXG : 0.70 (-4.11%)
COF : 87.52 (-0.31%)
RBCN : 7.75 (+0.52%)
Interpace Diagnostics Announces New Coverage of Thyroid Testing by Medica

Key Regional Health Plan Further Expands Number of Covered Lives to Over 280 Million

IDXG : 0.70 (-4.11%)
Interpace Diagnostics Group Reports Full Year and Fourth Quarter 2018 Financial Results

Business Progress and Recent Accomplishments Highlighted and Discussed Further on Conference Call

IDXG : 0.70 (-4.11%)
Interpace Diagnostics Announces Preliminary 2018 Revenues

Interpace to Host Fourth Quarter and Full Year 2018 Results Conference Call/Webcast

IDXG : 0.70 (-4.11%)
Interpace Diagnostics to Attend BIO CEO & Investor Conference in New York City

Interpace Diagnostics Group (NASDAQ: IDXG) today announced the Company will attend the 21 BIO CEO & Investor Conference being held in New York, NY at the New York Marriott Marquis on February 11 & 12,...

IDXG : 0.70 (-4.11%)
Interpace Diagnostics Announces Closing of $7.0 Million Public Offering of Common Stock

Interpace Diagnostics Group, Inc. (Nasdaq: IDXG) ("Interpace" or the "Company") today announced the closing of its previously announced underwritten public offering of 9,333,334 shares of its common stock...

IDXG : 0.70 (-4.11%)
Interpace Diagnostics Announces Proposed Public Offering of Common Stock

Interpace Diagnostics Group, Inc. (Nasdaq: IDXG) ("Interpace" or the "Company") announced today that it intends to offer and sell shares of its common stock in a registered underwritten public offering....

IDXG : 0.70 (-4.11%)
Interpace Diagnostics Announces Further Expansion of Thyroid Business

Interpace Only Provider Validated to Offer MDx Tests on Three Distinct Platforms

IDXG : 0.70 (-4.11%)
LH : 152.39 (-1.02%)
Interpace Diagnostics Enters into Agreement with University of Maryland Medical System

Agreement Provides Access to Company's Available Molecular Diagnostic Tests

IDXG : 0.70 (-4.11%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 48% Sell with a Weakening short term outlook on maintaining the current direction.

Longer term, the trend strength is Weak. Long term indicators fully support a continuation of the trend.

See More Share

Trade IDXG with:

Business Summary

Interpace Diagnostics Group, Inc. provides molecular diagnostic tests. The company's test consists of ThyGenX Thyroid Oncogene Panel (R), Thyroid miRNA(TM) and PancraGen(TM). Interpace Diagnostics Group Inc, formerly known as PDI Inc., is headquartered in Parsippany, New Jersey.

See More

Key Turning Points

2nd Resistance Point 0.80
1st Resistance Point 0.76
Last Price 0.70
1st Support Level 0.71
2nd Support Level 0.68

See More

52-Week High 1.78
Fibonacci 61.8% 1.36
Fibonacci 50% 1.23
Fibonacci 38.2% 1.10
Last Price 0.70
52-Week Low 0.67

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar